← Browse by Condition
Medical Condition
neuroendocrine tumors
Total Trials
11
Recruiting Now
11
Trial Phases
Phase 2, Phase 1
NCT04888481 Phase 2
Recruiting
68Ga-HA-DOTATATE Imaging of Suspected Somatostatin Receptor Positive Tumors
Enrollment
600 pts
Location
Canada
Sponsor
University of Alberta
NCT04949282
Recruiting
Spanish Series of Patients Treated With the Radionuclide Lutetium177
Enrollment
5,000 pts
Location
Spain
Sponsor
Sociedad Española de Medicina ...
NCT05804331
Recruiting
The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study
Enrollment
500 pts
Location
Australia
Sponsor
Western Sydney Local Health Di...
NCT07314164
Recruiting
Study of Cabozantinib in Participants With Neuroendocrine Tumors Who Have Already Received Prior Treatment
Enrollment
150 pts
Location
Austria, Germany
Sponsor
Ipsen
NCT05053854 Phase 1
Recruiting
PARP Inhibitor With 177Lu-DOTA-Octreotate PRRT in Patients With Neuroendocrine Tumours
Enrollment
24 pts
Location
Australia
Sponsor
Peter MacCallum Cancer Centre,...
NCT04090034
Recruiting
Peptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Neuroendocrine Tumors
Enrollment
50 pts
Location
United States
Sponsor
Methodist Health System
NCT05556473 Phase 1
Recruiting
F-Tryptophan PET/CT in Human Cancers
Enrollment
24 pts
Location
United States
Sponsor
Barbara Ann Karmanos Cancer In...
NCT04464122
Recruiting
Rediscovering Biomarkers for the Diagnosis and Early Treatment Response in NEN (REBORN)
Enrollment
60 pts
Location
Italy
Sponsor
University of Roma La Sapienza
NCT06344507
Recruiting
Iconographic Registry of Pancreatobiliary Endoscopy Procedures
Enrollment
12,000 pts
Location
Italy
Sponsor
IRCCS San Raffaele
NCT04119024 Phase 1
Recruiting
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Enrollment
18 pts
Location
United States
Sponsor
Anusha Kalbasi
NCT06430021
Recruiting
Study of the Value of hPG80 (Circulating Progastrin) for the Diagnosis of Neuroendocrine Tumours in Patients With an MEN1 Mutation
Enrollment
297 pts
Location
France
Sponsor
Centre Hospitalier Universitai...